chenodeoxycholic acid has been researched along with Diabetic Cardiomyopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Da, J; He, Y; Liu, G; Wu, H; Xie, B | 1 |
1 other study(ies) available for chenodeoxycholic acid and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Obeticholic acid protects against diabetic cardiomyopathy by activation of FXR/Nrf2 signaling in db/db mice.
Topics: Animals; Chenodeoxycholic Acid; Diabetic Cardiomyopathies; Fibrosis; Lipid Metabolism; Male; Mice; Myocardium; NF-E2-Related Factor 2; Oxidative Stress; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Up-Regulation | 2019 |